anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

158,341-158,400 of 319,975

filter-aware
82
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
83
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
84
The slide uses a comparison matrix to contrast three different therapeutic assets.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
85
The slide uses a process flow diagram to explain the biological mechanism of action.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
86
The slide uses a process flow diagram to explain the biological mechanism of action.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
87
The slide uses a linear process flow to explain the biological mechanism of the drug.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
88
The slide uses a process flow to show the mechanism of action for Nemvaleukin in the context of immuno-oncology.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
89
The slide uses a chevron-based process flow to show the transition from preclinical to clinical research.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
90
The diagram illustrates the biological process from tumor cell death to T-cell activation.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
91
The slide uses a vertical process diagram to illustrate the mechanism of ICD.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
92
The slide uses a biological process flow diagram to explain the therapeutic rationale.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
93
The slide demonstrates synergistic effects of combination therapy on immune cell infiltration.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
94
The chart demonstrates synergy between the two treatments.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
95
The slide presents two key metrics: tumor volume over time and Kaplan-Meier survival curves.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
96
The slide uses a vertical process diagram to explain the biological mechanism of ICD.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
97
The slide uses a 'problem-solution' structure, identifying the dual nature of chemo/radiation and proposing Nemvaleukin as a counter-measure.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
98
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
99
The slide uses a process flow diagram to map research stages to clinical outcomes.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
100
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
101
The slide uses a matrix-like structure to compare three distinct therapeutic approaches.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
102
The slide uses a diagram to illustrate the biological pathway from IL-12 to immune cell activation and subsequent downstream effects.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
103
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
104
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
105
The slide uses a four-step process flow to explain a drug delivery mechanism.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
106
The slide shows two line charts comparing tumor and blood concentration over time for two different subunits.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
107
The slide shows significantly higher accumulation of targeted subunits compared to non-targeted IL-12 in murine CT-26 tumor models.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
108
Statistical significance markers (asterisks) indicate differences between treatment groups.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
109
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
110
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
111
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
112
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
113
Scientific illustration of neurobiology concepts.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
114
The slide uses a categorization framework to group diseases by type.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
115
The slide uses a biological mechanism diagram to explain the therapeutic rationale for HDAC inhibitors.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
116
The slide uses a phylogenetic-style tree to categorize HDACs and a cluster diagram to show protein complex composition.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
117
Scientific presentation slide detailing molecular binding mechanism.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
118
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
119
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
120
The slide uses a three-column layout with checkmarks to indicate goal achievement.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
121
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
122
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
123
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
124
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
125
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
126
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
127
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
128
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
129
The slide features the company logo and a scientific illustration of antibodies.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
130
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
131
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
132
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
01
Slide 1
Anghami | SPAC Presentation Deck | 48 slidesAnghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
02
Anghami | SPAC Presentation Deck | 48 slidesAnghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
03
Anghami | SPAC Presentation Deck | 48 slidesAnghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
04
Anghami | SPAC Presentation Deck | 48 slidesAnghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
05
The slide uses a numbered list to highlight key investment theses.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
06
The slide uses a 2x3 grid of big-number metrics to establish market dominance.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
07
The slide uses a 2x2 grid layout for metrics.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
08
Data source: Global Web Index, Nov '19; Egypt (n=202), Saudi Arabia (n=211), UAE (n=200).Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank 1 hit
09
The slide uses a combination of a bar chart for revenue and a line chart for EBITDA margin to demonstrate financial health.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank Loop · Zoom In1 hit